Iizuka A, Kanda M, Sato Y, Shimizu D, Umeda S, Tanaka H
Ann Surg Oncol. 2025; .
PMID: 40080367
DOI: 10.1245/s10434-025-17109-y.
Strathearn L, Spender L, Schoenherr C, Mason S, Edwards R, Blyth K
Cells. 2024; 13(18.
PMID: 39329715
PMC: 11429573.
DOI: 10.3390/cells13181530.
Wang B, Jiang Y, Zhu J, Wu H, Wu J, Li L
Front Oncol. 2024; 14:1445415.
PMID: 39156699
PMC: 11327152.
DOI: 10.3389/fonc.2024.1445415.
Dai T, Qiu S, Gao X, Zhao C, Ge Z, Yang Y
Cancer Sci. 2024; 115(3):974-988.
PMID: 38287200
PMC: 10921006.
DOI: 10.1111/cas.16067.
Ungefroren H, Reimann J, Konukiewitz B, Braun R, Wellner U, Lehnert H
Biomedicines. 2024; 12(1).
PMID: 38255305
PMC: 10813112.
DOI: 10.3390/biomedicines12010199.
Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394.
Siljamaki E, Riihila P, Suwal U, Nissinen L, Rappu P, Kallajoki M
Oncogene. 2023; 42(49):3633-3647.
PMID: 37864034
PMC: 10691969.
DOI: 10.1038/s41388-023-02863-8.
The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence.
Maspero M, Yilmaz S, Cazzaniga B, Raj R, Ali K, Mazzaferro V
JHEP Rep. 2023; 5(11):100846.
PMID: 37771368
PMC: 10523008.
DOI: 10.1016/j.jhepr.2023.100846.
Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
Choi H, Chang J
Int J Mol Sci. 2023; 24(17).
PMID: 37686423
PMC: 10487969.
DOI: 10.3390/ijms241713618.
TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation.
Ungefroren H, Konukiewitz B, Braun R, Wellner U, Lehnert H, Marquardt J
Cancers (Basel). 2023; 15(15).
PMID: 37568607
PMC: 10417771.
DOI: 10.3390/cancers15153791.
MDM2- an indispensable player in tumorigenesis.
Zafar A, Khan M, Naeem A
Mol Biol Rep. 2023; 50(8):6871-6883.
PMID: 37314603
PMC: 10374471.
DOI: 10.1007/s11033-023-08512-3.
Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma.
Hahn S, Oh B, Kim H, Han I, Shin S, Kim G
Am J Cancer Res. 2023; 13(5):1806-1825.
PMID: 37293149
PMC: 10244103.
TGFβ1 regulates HRas-mediated activation of IRE1α through the PERK-RPAP2 axis in keratinocytes.
Mogre S, Blazanin N, Walsh H, Ibinson J, Minnich C, Hu C
Mol Carcinog. 2022; 61(10):958-971.
PMID: 35975910
PMC: 9486931.
DOI: 10.1002/mc.23453.
Regulation and Signaling of TGF-β Autoinduction.
Hariyanto N, Yo E, Wanandi S
Int J Mol Cell Med. 2022; 10(4):234-247.
PMID: 35875336
PMC: 9273153.
DOI: 10.22088/IJMCM.BUMS.10.4.234.
The Anti-Rheumatic Drug, Leflunomide, Induces Nephrotoxicity in Mice via Upregulation of TGFβ-Mediated p53/Smad2/3 Signaling.
Aljohani A, Alqarni Y, Alrashidi M, Aljuhani M, Shehata S, El-Kherbetawy M
Toxics. 2022; 10(5).
PMID: 35622687
PMC: 9144816.
DOI: 10.3390/toxics10050274.
Oncogenic Role of Connective Tissue Growth Factor Is Associated with Canonical TGF-β Cascade in Colorectal Cancer.
Hosseini S, Rejali L, Pezeshkian Z, Malekian M, Fatemi N, Peyravian N
Genes (Basel). 2022; 13(4).
PMID: 35456495
PMC: 9031605.
DOI: 10.3390/genes13040689.
Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment.
Bao Q, Huang Q, Chen Y, Wang Q, Sang R, Wang L
Front Mol Biosci. 2022; 8:796385.
PMID: 35059436
PMC: 8764126.
DOI: 10.3389/fmolb.2021.796385.
It's Time to Shift the Paradigm: Translation and Clinical Application of Non-αvβ3 Integrin Targeting Radiopharmaceuticals.
Kossatz S, Beer A, Notni J
Cancers (Basel). 2021; 13(23).
PMID: 34885066
PMC: 8657165.
DOI: 10.3390/cancers13235958.
Genetic variation of as a protective genotype for the development of colorectal cancer in men.
Stanilov N, Grigorova A, Velikova T, Stanilova S
World J Gastrointest Oncol. 2021; 13(11):1766-1780.
PMID: 34853649
PMC: 8603459.
DOI: 10.4251/wjgo.v13.i11.1766.
Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition.
Hua W, Kostidis S, Mayboroda O, Giera M, Hornsveld M, Ten Dijke P
Metabolites. 2021; 11(9).
PMID: 34564442
PMC: 8464788.
DOI: 10.3390/metabo11090626.
PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
Quigley N, Steiger K, Hoberuck S, Czech N, Zierke M, Kossatz S
Eur J Nucl Med Mol Imaging. 2021; 49(4):1136-1147.
PMID: 34559266
PMC: 8460406.
DOI: 10.1007/s00259-021-05559-x.